Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of High-Risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome Using Reduced-Intensity Conditioning with Fludarabine and Melphalan

Reduced-intensity conditioning has extended the use of allogeneic hematopoietic stem cell transplantation (HSCT) to patients otherwise not eligible for this treatment due to older age or frailty. One hundred twelve acute myelogenous leukemia/myelodysplastic syndromes patients received fludarabine an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Oran, Betul, Giralt, Sergio, Saliba, Rima, Hosing, Chitra, Popat, Uday, Khouri, Issa, Couriel, Daniel, Qazilbash, Muzaffar, Anderlini, Paolo, Kebriaei, Partow, Ghosh, Shubhra, Carrasco-Yalan, Antonio, de Meis, Ernesto, Anagnostopoulos, Athanasios, Donato, Michele, Champlin, Richard E., de Lima, Marcos
Format: Artigo
Idioma:Inglês
Publicat: 2007
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080636/
https://ncbi.nlm.nih.gov/pubmed/17382251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2006.11.024
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars